a dose-finding pilot study including six patients concluded that isradipine at an initial rate of 0.6 microgram/kg/minute , decreasing to 0.3 microgram/kg/minute with further adjustments as necessary , was safe for the treatment of post-aortocoronary bypass graft hypertension .
C0071304
isradipine
C0020538
hypertension